NovaScan’s nsCanary™ Tech Platform Named One of Five Finalists in AGA’s Shark Tank Competition
March 5th, 2023 by NovaScanProgram Recognizes Groundbreaking Technologies that Change the GI Landscape
NovaScan Announces the Launch of a Human GI trial for its nsCanary™ Cancer Detection Device
January 10th, 2023 by NovaScanJan 9, 2023, Chicago, IL – NovaScan, a clinical stage oncology company based in Chicago, announced that it has started a human GI clinical...
NovaScan’s Les Bogdanowicz Invited to Present Results at CHEST Annual Meeting
August 17th, 2022 by NovaScanNovaScan, an emerging oncology company based in Chicago, announced that CTO Les Bogdanowicz, PhD has been invited to present the results fro...
NovaScan Invited for Poster Presentation at ACG Annual Meeting
August 17th, 2022 by NovaScanNovaScan, a clinical stage oncology company based in Chicago, announced that it will be presenting a poster at ACG Annual Scientific Meeting...
Dr Amit Mehta to Advise NovaScan
August 10th, 2022 by NovaScanDr Amit Mehta to Advise NovaScan on Ex Vivo Scanning Product
NovaScan announces Luminary Scientific Advisory Board Leaders in Pulmonary and Gastroenterology
May 5th, 2022 by NovaScanChicago IL: NovaScan, a clinical-stage oncology company based in Chicago, has announced the appointment of a luminaries in gastroeneterology...
NovaScan Lung Studies Published in a Leading Peer Reviewed Journal
March 1st, 2022 by NovaScanNovaScan, a clinical-stage oncology company based in Chicago and Milwaukee, recently had its publication titled "The Cole Relaxation Freque...
NovaScan Completes $8MM Series B Financing
November 18th, 2021 by NovaScanCHICAGO, IL, USA, November 17, 2021 /EINPresswire.com/ -- NovaScan, a clinical stage oncology company pioneering a new low cost point of c...